Recipharm wins SwedenBIO Award
Advertisement
The winner of the ninth annual SwedenBIO Award was announced on 4th June. This year Recipharm AB was honoured for its efforts and contribution to Sweden life science during the past year.
The citation reads: "Recipharm has purposefully and with great skill built a solid organisation with a critical mass. A good revenue model has contributed to that the company created jobs in Sweden, but also established itself internationally. Recipharm is an extraordinary life science company that during the year strongly contributed to an increased interest in the industry and is an inspiring example for the whole of Swedish life science industry."
The prize is awarded to a company that demonstrated achievements and success beyond the norm in the life science industry in the past year and that has contributed to an increased interest in the business.
Most read news
Organizations
Other news from the department business & finance
Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
Abnova and Clearbridge BioMedics Accelerate Circulating Tumor Cell System into the Research and In Vitro Diagnostic Markets
New building will help Almac serve customers from Argentina to Zimbabwe
Evidence of activity seen in new data from ASA404 prostate cancer trial
Chromos shareholders approve acquisition of Targeted Molecules Corporation and financing terms
Nobilon and NVI co-developing RSV vaccine
InterMed Discovery achieves Proof-of-Principle for IMD-026260 - Small molecule anti-cancer drug candidate based on Hif-1 modulation
Large international study finds memory in adults impacted by versions of 4 genes - Second study identifies brain-development genes associated with intracranial volume
Evolva acquires resveratrol programme from Fluxome
Network that plays crucial role in cell function and disease
Celera Genomics Receives NIH Grant to Develop and Commercialize Avian Flu Diagnostic Test